The Quidel® Molecular Direct C. difficile Assay is a qualitative, multiplexed in vitro diagnostic test for the direct detection of toxin A gene (tcdA) or toxin B gene (tcdB) sequences of toxigenic strains of Clostridium difficile from unformed (liquid or soft) stool specimens collected from patients suspected of having Clostridium difficile-Associated Disease (CDAD).

Download C. difficile Monograph

Apply for free evaluation kit

Benefits of Quidel® Molecular Direct C. difficile Assay Kits

Benefits
CE-IVD and IVD labelled
Cleared for use in the US with Life Technologies QuantStudio™ Dx and Applied Biosystems® 7500 Fast Dx
The Quidel® Molecular Direct C. difficile Assay is a qualitative, multiplexed in vitro diagnostic test for the direct detection of toxin A gene (tcdA) or toxin B gene (tcdB) sequences of toxigenic strains of Clostridium difficile from unformed (liquid or soft) stool specimens collected from patients suspected of having Clostridium difficile-Associated Disease (CDAD).
Helps achieve 99% sensitivity and 99% specificity
No sample prep required (just two dilutions)

Ordering Information

Product

Quantity

Cat. No.

Quidel® Molecular Direct C. difficile Assay
(For sale in the US and Europe only. The assay is validated for use on the QuantStudio™ Dx and Applied Biosystems® 7500 Fast Dx Real-Time Instruments.)

96 reactions

4476855

Quidel® Molecular Direct C. difficile External Controls

10 reactions

4481660

Videos & Webinars

Antibiotic-Resistance-Report-Pod